• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

    4/30/24 6:07:45 AM ET
    $ADCT
    $CDE
    $CHGG
    $COUR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Precious Metals
    Basic Materials
    Get the next $ADCT alert in real time by email

    U.S. stock futures were slightly lower this morning, with the Nasdaq futures falling around 0.1% on Tuesday.

    Shares of Medifast, Inc. (NYSE:MED) fell sharply in today's pre-market trading after the company reported mixed first-quarter financial results.

    Medifast posted adjusted earnings of 66 cents per share, missing market estimates of 78 cents per share. The company's quarterly sales came in at $174.739 million versus expectations of $168.900 million, according to data from Benzinga Pro.

    Medifast shares tumbled 15.6% to $29.95 in pre-market trading.

    Here are some big stocks recording losses in today's pre-market trading session.

    • Coursera, Inc. (NYSE:COUR) shares dipped 12.7% to $10.37 in pre-market trading after the company reported mixed first-quarter financial results and issued FY24 revenue guidance below estimates.
    • Chegg, Inc. (NYSE:CHGG) shares declined 12.1% to $6.30 in pre-market trading after the company posted first-quarter results and named Nathan Shultz as CEO.
    • ADC Therapeutics SA (NASDAQ:ADCT) fell 6.7% to $4.20 in pre-market trading. The company, earlier during the month, announced the completion of dose escalation in LOTIS-7, a Phase 1b open-label clinical trial evaluating ZYNLONTA in combination with glofitamab or mosunetuzumab in heavily pre-treated patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
    • Mesoblast Ltd (NASDAQ:MESO) shares declined 5.7% to $6.69 in pre-market trading.
    • Coeur Mining, Inc. (NYSE:CDE) shares fell 5.7% to $4.63 in pre-market trading.
    • Prudential plc (NYSE:PUK) slipped 5.1% to $17.84 in pre-market trading. Prudential, last month, reported worse-than-expected FY 2023 revenues and earnings.
    • Yum China Holdings, Inc. (NYSE:YUMC) shares declined 5.1% to $38.00 in pre-market trading. Yum China posted upbeat earnings for its first quarter, while sales missed expectations.
    • Sibanye Stillwater Limited (NYSE:SBSW) shares fell 5% to $4.82 in pre-market trading.
    • Rambus Inc. (NASDAQ:RMBS) shares declined 4.1% to $58.01 in pre-market trading following first-quarter results.

    Now Read This: Investor Sentiment Improves Further, Dow Jumps Over 100 Points

    Don't forget to check out our premarket coverage here

    Get the next $ADCT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADCT
    $CDE
    $CHGG
    $COUR

    CompanyDatePrice TargetRatingAnalyst
    Coeur Mining Inc.
    $CDE
    3/25/2026$27.00Outperform
    BMO Capital Markets
    Coeur Mining Inc.
    $CDE
    2/20/2026Buy → Hold
    Canaccord Genuity
    D/B/A Sibanye-Stillwater Limited
    $SBSW
    1/23/2026$24.80Hold → Buy
    HSBC Securities
    Rambus Inc.
    $RMBS
    1/22/2026Outperform
    William Blair
    Prudential Public Limited Company
    $PUK
    1/7/2026Buy
    Deutsche Bank
    Coursera Inc.
    $COUR
    12/17/2025$12.00Neutral → Overweight
    Analyst
    Mesoblast Limited
    $MESO
    11/25/2025Hold → Buy
    Jefferies
    Rambus Inc.
    $RMBS
    10/6/2025$100.00Positive → Neutral
    Susquehanna
    More analyst ratings

    $ADCT
    $CDE
    $CHGG
    $COUR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Johnson Nicholas Mark

    3 - MEDIFAST INC (0000910329) (Issuer)

    3/27/26 5:55:56 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    SEC Form 4 filed by Mackenzie Jonathan Barrett

    4 - MEDIFAST INC (0000910329) (Issuer)

    3/27/26 5:54:41 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    SEC Form 4 filed by Maloney James P.

    4 - MEDIFAST INC (0000910329) (Issuer)

    3/27/26 5:52:54 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    $ADCT
    $CDE
    $CHGG
    $COUR
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Rambus Inc.

    SCHEDULE 13G/A - RAMBUS INC (0000917273) (Subject)

    3/27/26 11:36:05 AM ET
    $RMBS
    Semiconductors
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by MEDIFAST INC

    SCHEDULE 13G/A - MEDIFAST INC (0000910329) (Subject)

    3/27/26 10:32:39 AM ET
    $MED
    Packaged Foods
    Consumer Staples

    SEC Form 6-K filed by D/B/A Sibanye-Stillwater Limited

    6-K - Sibanye Stillwater Ltd (0001786909) (Filer)

    3/27/26 9:34:14 AM ET
    $SBSW
    Precious Metals
    Basic Materials

    $ADCT
    $CDE
    $CHGG
    $COUR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (ORIG-1) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 04/23/2021. Application Category: BLA, Application Number: 761196, Application Classification:

    4/23/21 1:46:03 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $CDE
    $CHGG
    $COUR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $ADCT
    $CDE
    $CHGG
    $COUR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $ADCT
    $CDE
    $CHGG
    $COUR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    The $11B Mining Pivot: Why Capital is Securing High-Grade Gold & Silver Assets

    Issued on behalf of Golden Goose Resources Corp.VANCOUVER, BC, March 25, 2026 /CNW/ -- USANewsGroup.com Commentary - Global gold mine production is hitting a wall. High-grade discoveries are simply getting harder to find and structurally tougher to bring online[1]. Because of this, smart capital is strategically rotating toward scalable assets capable of replacing rapidly draining supplies. January 2026 alone saw over $11 billion in mining transactions. More than 77% of that merger and acquisition capital zeroed in on gold and silver[2]. Senior producers are making pivotal moves to secure ounces right now, knowing the supply response will lag behind price signals for years. Against this high

    3/25/26 10:15:00 AM ET
    $CDE
    $DVS
    $NFGC
    Precious Metals
    Basic Materials
    Metal Mining

    Coeur Provides Company Update Post-New Gold Closing

    Provides Consolidated 2026 Guidance and Announces Updated Capital Return Program Issues Updated Year-End Reserves and Resources for Rainy River and New Afton, Including Maiden K-Zone Resource at New Afton and Two Years of Additional Mine Life at Rainy River Coeur Mining, Inc. ("Coeur" or the "Company") ((NYSE, TSX:CDE) today provided a corporate update following the March 20, 2026 completion of the acquisition of New Gold Inc.("New Gold"), including consolidated 2026 guidance, 2025 mineral reserves and resources for the newly-acquired New Afton and Rainy River mines, and an updated financial policy highlighted by a robust new return of capital program. Highlights New Afton and Rain

    3/23/26 6:30:00 AM ET
    $CDE
    Precious Metals
    Basic Materials

    Coeur Mining, Inc. Announces Commencement of Exchange Offer and Consent Solicitation for New Gold Senior Notes

    Coeur Mining, Inc. ("Coeur" or the "Company") ((NYSE, TSX:CDE) today announced that it has commenced a private exchange offer to certain Eligible Holders (the "Exchange Offer") for any and all of the US$400,000,000 aggregate principal amount outstanding 6.875% Senior Notes due 2032 (CUSIP: 644535 AJ5 / C62944 AE0; ISIN: US644535AJ57 / USC62944AE04) (the "Existing Notes") issued by New Gold Inc. ("New Gold") for up to US$400,000,000 aggregate principal amount of new notes to be issued by Coeur (the "New Notes") and cash. In conjunction with the Exchange Offer, Coeur is concurrently soliciting consents (the "Consent Solicitation") to adopt certain proposed amendments to the indenture govern

    3/23/26 6:27:00 AM ET
    $CDE
    Precious Metals
    Basic Materials

    BMO Capital Markets resumed coverage on Coeur Mining with a new price target

    BMO Capital Markets resumed coverage of Coeur Mining with a rating of Outperform and set a new price target of $27.00

    3/25/26 8:52:52 AM ET
    $CDE
    Precious Metals
    Basic Materials

    Coeur Mining downgraded by Canaccord Genuity

    Canaccord Genuity downgraded Coeur Mining from Buy to Hold

    2/20/26 8:21:45 AM ET
    $CDE
    Precious Metals
    Basic Materials

    Sibanye-Stillwater upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Sibanye-Stillwater from Hold to Buy and set a new price target of $24.80

    1/23/26 8:11:36 AM ET
    $SBSW
    Precious Metals
    Basic Materials

    PRESIDENT, CEO, EXEC CHAIRMAN Rosensweig Daniel bought $56,360 worth of shares (100,000 units at $0.56), increasing direct ownership by 1% to 7,625,075 units (SEC Form 4)

    4 - CHEGG, INC (0001364954) (Issuer)

    2/18/26 6:30:27 AM ET
    $CHGG
    Other Consumer Services
    Real Estate

    Director Das Paramita bought $4,454 worth of shares (385 units at $11.57), increasing direct ownership by 0.50% to 76,920 units (SEC Form 4)

    4 - Coeur Mining, Inc. (0000215466) (Issuer)

    8/14/25 4:46:50 PM ET
    $CDE
    Precious Metals
    Basic Materials

    Chairman & CEO Chard Daniel R bought $5,003 worth of shares (381 units at $13.13) (SEC Form 4)

    4 - MEDIFAST INC (0000910329) (Issuer)

    6/17/25 6:20:00 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    $ADCT
    $CDE
    $CHGG
    $COUR
    Financials

    Live finance-specific insights

    View All

    The $11B Mining Pivot: Why Capital is Securing High-Grade Gold & Silver Assets

    Issued on behalf of Golden Goose Resources Corp.VANCOUVER, BC, March 25, 2026 /CNW/ -- USANewsGroup.com Commentary - Global gold mine production is hitting a wall. High-grade discoveries are simply getting harder to find and structurally tougher to bring online[1]. Because of this, smart capital is strategically rotating toward scalable assets capable of replacing rapidly draining supplies. January 2026 alone saw over $11 billion in mining transactions. More than 77% of that merger and acquisition capital zeroed in on gold and silver[2]. Senior producers are making pivotal moves to secure ounces right now, knowing the supply response will lag behind price signals for years. Against this high

    3/25/26 10:15:00 AM ET
    $CDE
    $DVS
    $NFGC
    Precious Metals
    Basic Materials
    Metal Mining

    Coeur Provides Company Update Post-New Gold Closing

    Provides Consolidated 2026 Guidance and Announces Updated Capital Return Program Issues Updated Year-End Reserves and Resources for Rainy River and New Afton, Including Maiden K-Zone Resource at New Afton and Two Years of Additional Mine Life at Rainy River Coeur Mining, Inc. ("Coeur" or the "Company") ((NYSE, TSX:CDE) today provided a corporate update following the March 20, 2026 completion of the acquisition of New Gold Inc.("New Gold"), including consolidated 2026 guidance, 2025 mineral reserves and resources for the newly-acquired New Afton and Rainy River mines, and an updated financial policy highlighted by a robust new return of capital program. Highlights New Afton and Rain

    3/23/26 6:30:00 AM ET
    $CDE
    Precious Metals
    Basic Materials

    High-Margin Mining: How the Smart Money Is Navigating the New Gold Supercycle

    Issued on behalf of Lake Victoria Gold Ltd.VANCOUVER, BC, March 18, 2026 /CNW/ -- USANewsGroup.com -- Gold is moving way beyond a simple tactical trade; we are seeing a fundamental, structural shift in global demand. For nine months straight, gold ETFs have seen massive capital inflows, pushing total assets to historic highs[1]. This capital rotation into safe-haven assets is accelerating as the smart money hedges against dollar weakness and a long-term macro realignment[2]. In this environment, Lake Victoria Gold Ltd. (TSXV:LVG) (OTCQB:LVGLF), Equinox Gold (NYSE-A: EQX) (TSX:EQX), Coeur Mining (NYSE:CDE), New Gold (NYSE-A: NGD) (TSX:NGD), and Aris Mining (NYSE:ARIS) (TSX:ARIS) represent the

    3/18/26 10:00:00 AM ET
    $ARIS
    $CDE
    $EQX
    Precious Metals
    Basic Materials
    Metal Mining

    $ADCT
    $CDE
    $CHGG
    $COUR
    Leadership Updates

    Live Leadership Updates

    View All

    Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast

    NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the appointment of Teresa Montagut MD, PhD in the newly established position of Head of Clinical Development and Medical Affairs reporting to the Chief Medical Officer Dr. Eric Rose. In this role, Teresa will lead Mesoblast's medical affairs organization, fostering clinical collaborations and spearheading investigator-initiated trials, enhancing clinical and medical communications, and engaging with healthcare professionals. She will play a critical role in unlocking the value of Mesoblast's cell therapy programs i

    3/11/26 7:21:39 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Victor Peng Joins Rambus Board of Directors

    Rambus Inc. (NASDAQ: RMBS), a premier chip and silicon IP provider making data faster and safer, today announced the appointment of Victor Peng to its Board of Directors, effective Thursday, February 12, 2026. Mr. Peng is an accomplished executive with more than 40 years of leadership experience at top semiconductor companies. Most recently, Mr. Peng served as president of Advanced Micro Devices (AMD), leading AMD's embedded and data center GPU businesses, AI software, and the research and advanced development group. Prior to AMD, Mr. Peng served 14 years at Xilinx, holding senior level positions including president and chief executive officer, board member, chief operating officer, execu

    2/12/26 4:05:00 PM ET
    $RMBS
    Semiconductors
    Technology

    Chegg Appoints Karine Allouche as General Manager, Language Learning, Worldwide and Skills Integration, Europe

    Chegg, Inc. (NYSE:CHGG), a global learning company, today announced that Karine Allouche will join Busuu, Chegg's language learning business, as General Manager of Language Learning, Worldwide, and Skills Integration, Europe, effective February 9, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209423954/en/Karine Allouche In her role, Karine will focus on strengthening execution, accelerating growth, and deepening collaboration across the company, in partnership with Chegg's leadership team and the board. In addition to leading language learning, Karine will own Chegg's European commercial engine and play a key role in

    2/9/26 9:05:00 AM ET
    $CHGG
    Other Consumer Services
    Real Estate

    $ADCT
    $CDE
    $CHGG
    $COUR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by ADC Therapeutics SA

    SC 13G/A - ADC Therapeutics SA (0001771910) (Subject)

    11/14/24 9:00:57 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Coursera Inc.

    SC 13G - Coursera, Inc. (0001651562) (Subject)

    11/14/24 4:11:51 PM ET
    $COUR
    Computer Software: Prepackaged Software
    Technology